Showing all 2 results
Hydrocortisone Oromucosal Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Mucoadhesive Pellet/Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the highly hygroscopic polymers do not prematurely swell from atmospheric humidity.
Active Ingredient Strength Primary Clinical Function Hydrocortisone (as Sodium Succinate or Acetate) USP/Ph.Eur. 2.5 mg Global Oral Pathology Standard: The definitive micro-dose engineered specifically for localized mucosal absorption, maximizing ulcer healing while neutralizing systemic exposure. Excipients Carbomer / Hypromellose (HPMC) / Lactose Monohydrate / Polycarbophil / Magnesium Stearate Bio-Adhesive Polymers / Matrix Former / Diluent / Lubricant (Engineered utilizing elite hydrophilic polymers that instantly cross-link upon contact with saliva, converting the hard tablet into an immovable, slow-release mucosal patch) *Pack Sizes: 10×10 Alu-Alu Blisters or Tubes of 20 (Optimized specifically for the short-term, acute treatment of cyclical ulcer outbreaks).
Nimesulide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Burst Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active ingredient.
Active Ingredient Strength Primary Clinical Function Nimesulide BP/Ph.Eur. 100 mg Global Acute Standard: High-efficacy adult therapeutic unit for the rapid, short-term abortion of acute inflammatory pain. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Docusate Sodium / Povidone K30 / Magnesium Stearate Diluent / Superdisintegrant / Wetting Surfactant / Binder (Engineered specifically to trigger a violent, immediate structural collapse in the stomach, maximizing the drug’s surface area for ultra-fast gastrointestinal absorption) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, short-term acute dispensing to ensure patients do not exceed the mandated 15-day therapy limit).
